Larvol Cliniclarvol.hashnode.devยทAug 23, 2024Impact of IDH2 Variants and Co-Mutations on Survival in Relapsed/Refractory AMLAbstract Limited treatment options are available for patients with relapsed/refractory acute myeloid leukemia (R/R AML). We recently reported results from the phase 3 IDHENTIFY trial (NCT02577406) showing improved response rates and event-free surviv...TumorAdd a thoughtful commentNo comments yetBe the first to start the conversation.
